BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32349388)

  • 1. Integrative Transcriptome Analyses of the Human Fallopian Tube: Fimbria and Ampulla-Site of Origin of Serous Carcinoma of the Ovary.
    Sowamber R; Nelson O; Dodds L; DeCastro V; Paudel I; Milea A; Considine M; Cope L; Pinto A; Schlumbrecht M; Slomovitz B; Shaw PA; George SHL
    Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32349388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 3. Proliferation in the normal FTE is a hallmark of the follicular phase, not BRCA mutation status.
    George SH; Milea A; Shaw PA
    Clin Cancer Res; 2012 Nov; 18(22):6199-207. PubMed ID: 22967960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Methylome Analyses Implicate Fallopian Tube Epithelia as the Origin for High-Grade Serous Ovarian Cancer.
    Klinkebiel D; Zhang W; Akers SN; Odunsi K; Karpf AR
    Mol Cancer Res; 2016 Sep; 14(9):787-94. PubMed ID: 27259716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium.
    Qiu C; Lu N; Wang X; Zhang Q; Yuan C; Yan S; Dongol S; Li Y; Sun X; Sun C; Zhang Z; Zheng W; Kong B
    Gynecol Oncol; 2017 Dec; 147(3):634-641. PubMed ID: 28965696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Origins of High-Grade Serous Ovarian Cancer.
    Kim J; Park EY; Kim O; Schilder JM; Coffey DM; Cho CH; Bast RC
    Cancers (Basel); 2018 Nov; 10(11):. PubMed ID: 30424539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma.
    Tone AA; Begley H; Sharma M; Murphy J; Rosen B; Brown TJ; Shaw PA
    Clin Cancer Res; 2008 Jul; 14(13):4067-78. PubMed ID: 18593983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oncopathological aspects of BRCA1 and BRCA2 genes inactivation in tumors of ovary, fallopian tube and pelvic peritoneum].
    Škapa P; Dundr P
    Cesk Patol; 2016; 52(4):199-204. PubMed ID: 27869446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas.
    Gilks CB; Irving J; Köbel M; Lee C; Singh N; Wilkinson N; McCluggage WG
    Am J Surg Pathol; 2015 Mar; 39(3):357-64. PubMed ID: 25517954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.
    Medeiros F; Muto MG; Lee Y; Elvin JA; Callahan MJ; Feltmate C; Garber JE; Cramer DW; Crum CP
    Am J Surg Pathol; 2006 Feb; 30(2):230-6. PubMed ID: 16434898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors].
    Wen J; Shi JL; Shen DH; Chen YX; Song QJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A candidate precursor to serous carcinoma that originates in the distal fallopian tube.
    Lee Y; Miron A; Drapkin R; Nucci MR; Medeiros F; Saleemuddin A; Garber J; Birch C; Mou H; Gordon RW; Cramer DW; McKeon FD; Crum CP
    J Pathol; 2007 Jan; 211(1):26-35. PubMed ID: 17117391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphological features of the fimbria of the fallopian tube in pelvic serous adenocarcinoma].
    Guo DH; Pang SJ; Shen Y; Li Y
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):287-90. PubMed ID: 21575501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fallopian tube secreted protein affects ovarian metabolites in high grade serous ovarian cancer.
    Bergsten TM; Levy SE; Zink KE; Lusk HJ; Pergande MR; Cologna SM; Burdette JE; Sanchez LM
    Front Cell Dev Biol; 2022; 10():1042734. PubMed ID: 36420136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased progesterone receptor isoform expression in luteal phase fallopian tube epithelium and high-grade serous carcinoma.
    Tone AA; Virtanen C; Shaw PA; Brown TJ
    Endocr Relat Cancer; 2011 Apr; 18(2):221-34. PubMed ID: 21263043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fallopian Tube Lesions in Women at High Risk for Ovarian Cancer: A Multicenter Study.
    Visvanathan K; Shaw P; May BJ; Bahadirli-Talbott A; Kaushiva A; Risch H; Narod S; Wang TL; Parkash V; Vang R; Levine DA; Soslow R; Kurman R; Shih IM
    Cancer Prev Res (Phila); 2018 Nov; 11(11):697-706. PubMed ID: 30232083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current FIGO staging classification for cancer of ovary, fallopian tube and peritoneum].
    Šišovská I; Minář L; Felsinger M; Anton M; Bednaříková M; Hausnerová J; Jandáková E; Weinberger V
    Ceska Gynekol; 2017; 82(3):230-236. PubMed ID: 28593778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
    BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serous tubal intraepithelial carcinoma, chronic fallopian tube injury, and serous carcinoma development.
    Malmberg K; Klynning C; Flöter-Rådestad A; Carlson JW
    Virchows Arch; 2016 Jun; 468(6):707-13. PubMed ID: 27003156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift.
    Reade CJ; McVey RM; Tone AA; Finlayson SJ; McAlpine JN; Fung-Kee-Fung M; Ferguson SE
    J Obstet Gynaecol Can; 2014 Feb; 36(2):133-140. PubMed ID: 24518912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.